CAPR   $14.35  -3.50% Market Closed After Close 14.24 -0.77%

Capricor Therapeutics Inc
Last Events:

2023-08-09 Signal in MACD changed from bearish weakening to bullish. Oscillator MACD is in the positive territory it's higher than the signal line and it crossed the zero line from the bottom. These factors mean that there is probably a growing trend. Last signal: up-crossing the middle level.

2023-08-09 Trend Power changed from almost flat to slow.

2023-08-06 Signal in Stochastic changed from bullish weakening to bullish recovery. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: main and signal line crossing.

2023-08-06 Signal in RSI changed from bearish weakening to bullish. RSI indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: exit from the overbought zone.

2023-08-06 Signal in EMA100 changed from bearish reversal to bullish reversal. The price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.

2023-08-06 Signal in EMA50 changed from bearish reversal to bullish reversal. The price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.

2023-08-06 Signal in EMA20 changed from bearish reversal to bullish reversal. The price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.

2023-08-05 Signal in Stochastic changed from bullish to bullish weakening. The stochastic indicator is in the upper part of the neutral territory and it falls. These factors indicate that the downside trend is confirmed. Last signal: main and signal line crossing.


Current temperature: 0.00
ST: 0, Cor:

50-50 Year Forecast
Low with % probability:
Target: 13.11
High with % probability:
Analyst Recommendations:
Number of estimates 7
Target Price Mean 41.29
Mean unverified/preliminary 41.29 / 41.29
Target Price Low / High 25.00 / 77.00
Median / STD DEV 39.00 / 16.92
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell None ActivelyBuy
rsi Sell ActivelyBuy None
macd None ActivelyBuy None
stoch ActivelyBuy None None
ma20 None Buy ActivelyBuy
ma50 None None None
ma100 None Sell None
Candlestick PatternDec. 10, 2024 Bullish Squeeze Alert - pattern is a made up of three candlesticks. A black candlestick appears on the first day in a downtrend. The second and third days each have lower highs and higher lows than the previous day. Their color is not important. Considered to be a bullish reversal pattern.
ISIN US14070B3096
ceo Dr. Linda Marbán Ph.D.
Website https://www.capricor.com
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment of duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase 3 clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD). It also focused on developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases. In addition, the company develops CAP-2003, under pre-clinical development for the treatment of trauma related injuries and conditions. It has collaboration and distribution agreement with Nippon Shinyaku Co. Ltd., collaboration agreement with National Institute of Allergy and Infectious Diseases, license agreements with the Johns Hopkins University and Cedars-Sinai Medical Center, as well as cell line license agreement with Life Technologies Corporation. The company was founded in 2005 and is headquartered in San Diego, California.